Thomas J. Herzog

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz et al. · New England Journal of Medicine · 2023 · 800 citations · Full text

Medicine, Oncology, Pharmacology +17

Nationwide Trends in the Performance of Inpatient Hysterectomy in the United States

Jason D. Wright, Thomas J. Herzog, Jennifer Tsui et al. · Obstetrics and Gynecology · 2013 · 761 citations · Full text

Medicine, Gynecology, Surgery +3

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

Robert L. Coleman, Mark F. Brady, Thomas J. Herzog et al. · The Lancet Oncology · 2017 · 602 citations · Full text

Medicine, Gynecology, Oncology +15

Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease

Jason D. Wright, Cande V. Ananth, Sharyn N. Lewin et al. · JAMA · 2013 · 578 citations

Medicine, Gynecology, Surgery +13

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Krishnansu S. Tewari, Robert A. Burger, Danielle Enserro et al. · Journal of Clinical Oncology · 2019 · 483 citations · Full text

Medicine, Gynecology, Oncology +12